Article Sidebar
Published:
Sep 29, 2022Keywords:
Article Details
Once the articles are published by the journal, they become the joint property of the journal and the author, and total or partial reproduction in other journals is prohibited, as well as translation into other languages without the authorization of the Rev. Ang. de Ciênc. da Saúde. When part of the
content of the articles is used in other works the source must be cited.
Main Article Content
Expected prevalence of Sheehan's syndrome in Mexico by extrapolation of screenings in other countries
Miriam Deyanira Rodriguez Piña
Nohemi Piña Vidal
Betsy Corina Sosa Garcia
Pamela Lagos Robles
Hugo Mendieta Zerón
Abstract
Background: Sheehan's syndrome (SS) occurs as result of ischemic pituitary necrosis due to postpartum hemorrhage; its prevalence in Mexico is unknown.
Objective: To estimate the approximate number of Mexican women that could have SS.
Methods: A search was performed in PubMed and Web of Science using the mesh terms: "postpartum hemorrhage" OR "Hypopituitarism". Besides these same keywords, in Google Scholar the search was expanded using the next terms: "Sheehan's syndrome prevalence". It was calculated the estimated cases of obstetric hemorrhage and the SS incidence in México based on casuistries from three countries.
Results: Extrapolating data from India, the total cases of SS in Mexico in the last five years could be as high as 322761 or about 2000 if taking Iceland’s statistics. As the measure of all the adenohypophyseal hormones is of 56 dollars in Mexican public institutions, the option to make and early SS diagnosis should be to quantify only TSH that has a cost of 13.5 dollars.
Conclusions: The prevalence of SS in Mexico can have a 161-fold difference between the minimum and maximum values calculated by extrapolating information from other countries, so it is important to consider screening alternatives such as TSH measurement for its detection.
